#214

top of page

Home
Join Now!
Podcast

Finer Market Points

VCP Library

Daily Market Report

Home
Join Now!
Podcast

All Posts
ASX Momentum Stocks

AVITA Medical, Inc. (ASX: AVH) — Two Catalysts, Twelve Days, a Doubled Share Price

AVITA Medical entered the FMP Top 10 on its Q2 CY2026 result and extended the run on a second catalyst — the PermeaDerm-I clinical study. Its ASX share price rose from A$1.28 to A$2.71 across the twelve days spanning the two announcements.

Christopher Hall

Aug 307 min read

Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680 (RBE) is incorporated in Australia with limited liability. RBE and affiliated entities may have commercial or financial interests in the companies or products mentioned This information is directed and available to and for the benefit of Australian residents only and is not an advertisement, recommendation, forecast or advice. As this information has been prepared without considering your objectives, financial or taxation situation or needs, you should consider, before acting on this material, consider its appropriateness to your circumstances and seek appropriate professional advice. RBE and its related entities do not accept any liability for any loss or damages arising out of or in relation to the use of all or any part of this information. We believe that this information is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability, or completeness. This information is published solely for informational purposes and is not to be constructed as a solicitation or an offer to buy, sell or hold any securities, financial instruments or services in any jurisdiction. This information is under copyright to RBE and may not be used without prior consent.

Home
Join Now!
Podcast

bottom of page